أرسل هذا في رسالة قصيرة: A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1)

  ______     ___     _    _    _    _     _____   
 /_____//   / _ \\  | |  | || | || | ||  /  ___|| 
 `____ `   / //\ \\ | |/\| || | || | || | // __   
 /___//   |  ___  |||  /\  || | \\_/ || | \\_\ || 
 `__ `    |_||  |_|||_// \_||  \____//   \____//  
 /_//     `-`   `-` `-`   `-`   `---`     `---`   
 `-`